Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Hong Kong Court of Final Appeal confirms extended powers of SFC to prosecute New York hedge fund for insider trading

Wednesday, May 29, 2013

Bailey McCann, Opalesque New York:

Tiger Asia Management, a New York-based hedge fund will be prosecuted by the Hong Kong financial regulator following a landmark court decision handed down in Hong Kong on May 10. Hong Kong's Securities and Futures Commission (SFC), went after Tiger Asia Management for breaking trading rules in its market. Originally, the fund pushed back saying that it was US based and that the SFC exceeded its regulatory authority when it attempted to go after the fund for insider trading. The court however, has sided with the SFC, now the regulator will move forward with its case which is the latest in several recent prosecutions of insider trading in Hong Kong.

The SFC is moving aggressively on insider trading in Hong Kong. Tiger Asia Management had investments throughout Asia including China, Japan and Korea and the SFC said in its claim that it had the right to go after the firm on an extraterritorial basis. This claim is notable as it sets up an allowance for the regulator to pursue other firms outside of Hong Kong who engage in insider trading in the country.

According to the South China Morning Post, the regulator will now have to make its case through two court proce......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its